Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)
European Journal of Neurology · 2026-06 · 33 (6)
DOI: 10.1111/ene.70657 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Neurology, online erschienen am 01.06.2026. Verfasst von Marco Ceccanti und 53 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The F64L variant is among the most frequent TTR mutations in Italy, typically associated with a predominantly neurologic phenotype and limited cardiac involvement.
Methods
Data from 181 ATTRv patients in the multicenter Patisiranitaly database treated with Patisiran since 2020 were analyzed. Neurologic impairment scores, Norfolk QoL‐DN, and cardiac parameters were compared between F64L ( n = 56), V30M ( n = 37), and non‐F64L ( n = 125) patients at baseline and during follow‐up. Cluster analysis was applied to identify patient subgroups based on these variables.
Results
F64L represented 30.9% of the cohort. Compared to non‐F64L patients, F64L patients had a higher prevalence of neurologic onset and neurologic phenotype, a thinner interventricular septum, and lower NT‐proBNP levels. Cluster analysis segregated patients into two distinct groups, predominantly reflecting F64L vs. non‐F64L status and corresponding neurologic severity. F64L patients showed milder cardiac involvement compared to V30M patients. Longitudinal repeated‐measures ANOVA showed stable clinical and instrumental measures.
Conclusions
F64L is characterized by predominant neurologic involvement and milder cardiac involvement in this Patisiran‐treated cohort. Mutation‐specific diagnostic and follow‐up strategies are essential to capture its natural history and treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
- Dipartimento Di Neuroscienze, Organi Di Senso E Torace, UOC Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 8, Rome, Italy.
- Department of Neurology, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome and UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
- AOU Careggi and Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
- Neurology Unit, Department of Neuroscience, University of Padua, Padua, Italy.
ORCID-Profile: Marco Ceccanti, Angela Romano, Massimiliano Filosto, Luca Leonardi, Fiore Manganelli, Giammarco Milella, Davide Pareyson, Luca Guglielmo Pradotto, Matteo Tagliapietra, Francesca Vitali, Nicasio Rini, Roberto D'Angelo, Vincenzo Di Stefano
Zitieren
APA
Ceccanti, M., Guaraldi, P., Romano, A., Antonini, G., Barilaro, A., Briani, C., Burattini, M., Gianoli, M., Carlini, G., Cianci, V., Dossi, M. C., Di Lisi, D., Di Muzio, A., Ratti, A., Filosto, M., Gasverde, S., Gemelli, C., Gentile, L., Goglia, M., …, & Di Stefano, V. (2026). Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly). European Journal of Neurology, 33(6). https://doi.org/10.1111/ene.70657
Vancouver
Ceccanti M, Guaraldi P, Romano A, Antonini G, Barilaro A, Briani C, et al. Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly). European Journal of Neurology. 2026;33(6). doi:10.1111/ene.70657
BibTeX
@article{Ceccanti2026,
author = {Ceccanti, Marco and Guaraldi, Pietro and Romano, Angela and Antonini, Giovanni and Barilaro, Alessandro and Briani, Chiara and Burattini, Marco and Gianoli, Micol and Carlini, Giulia and Cianci, Vittoria and Dossi, Marco Currò and Di Lisi, Daniela and Di Muzio, Antonio and Ratti, Adele and Filosto, Massimiliano and Gasverde, Sabrina and Gemelli, Chiara and Gentile, Luca and Goglia, Mariangela and Leonardi, Luca and Longhi, Simone and Lotti, Antonio and Manganelli, Fiore and Mazzeo, Anna and Augello, Sofia Maria and Milella, Giammarco and Novo, Giuseppina and Pareyson, Davide and Fenu, Silvia and Palumbo, Giovanni and Petrelli, Cristina and Poli, Loris and Pradotto, Luca Guglielmo and Russo, Massimo and Salvalaggio, Alessandro and Sciarrone, Maria Ausilia and Sellitti, Luigi and Tagliapietra, Matteo and Tozza, Stefano and Castiglia, Mariagiovanna and Turri, Mara and Verriello, Lorenzo and Chimenti, Cristina and Vitali, Francesca and Brighina, Filippo and Rini, Nicasio and Inghilleri, Maurizio and D'Angelo, Roberto and Abelardo, Domenico and Cambieri, Chiara and Libonati, Laura and Moret, Federica and Luigetti, Marco and Di Stefano, Vincenzo},
title = {Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {6},
doi = {10.1111/ene.70657}
}
EUVIMED